ArticleFrontiers in oncology2021
Editorial: FDA-Approved Drug Repositioning for P-Glycoprotein Overexpressing Resistant Cancer.
Sungpil Yoon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticleFrontiers in oncology2021
Sungpil Yoon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.